{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:42:37Z","timestamp":1792402957925,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,11,6]],"date-time":"2009-11-06T00:00:00Z","timestamp":1257465600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s10549-009-0602-z","type":"journal-article","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T06:15:51Z","timestamp":1257401751000},"page":"745-754","source":"Crossref","is-referenced-by-count":65,"title":["Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model"],"prefix":"10.1007","volume":"122","author":[{"given":"Ianko D.","family":"Iankov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlos","family":"Msaouel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Federspiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy A.","family":"Bulur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan B.","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Gastineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James N.","family":"Ingle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanthia","family":"Galanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,6]]},"reference":[{"key":"602_CR1","doi-asserted-by":"crossref","unstructured":"Light RW (2002) Clinical practice. Pleural effusion. N Engl J Med 346(25):1971\u20131977","DOI":"10.1056\/NEJMcp010731"},{"issue":"Suppl 4","key":"602_CR2","doi-asserted-by":"crossref","first-page":"291S","DOI":"10.1378\/chest.112.4_Supplement.291S","volume":"112","author":"MM DeCamp Jr","year":"1997","unstructured":"DeCamp MM Jr, Mentzer SJ, Swanson SJ, Sugarbaker DJ (1997) Malignant effusive disease of the pleura and pericardium. Chest 112(Suppl 4):291S\u2013295S","journal-title":"Chest"},{"issue":"1","key":"602_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2006.04.016","volume":"54","author":"S Neragi-Miandoab","year":"2006","unstructured":"Neragi-Miandoab S (2006) Malignant pleural effusion, current and evolving approaches for its diagnosis and management. Lung Cancer 54(1):1\u20139","journal-title":"Lung Cancer"},{"issue":"2","key":"602_CR4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0025-6196(11)60848-3","volume":"83","author":"JE Heffner","year":"2008","unstructured":"Heffner JE, Klein JS (2008) Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clin Proc 83(2):235\u2013250","journal-title":"Mayo Clin Proc"},{"key":"602_CR5","unstructured":"Griffin D (2001) Measles virus. In: Knipe DM, Howley PM (eds) Fields virology, 4th edn. Lippincott, Williams & Wilkins, Philadelphia, PA, pp 1401\u20131441"},{"issue":"12","key":"602_CR6","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1182\/blood.V97.12.3746","volume":"97","author":"D Grote","year":"2001","unstructured":"Grote D, Russell SJ, Cornu TI, Cattaneo R, Vile R, Poland GA, Fielding AK (2001) Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. Blood 97(12):3746\u20133754","journal-title":"Blood"},{"issue":"7","key":"602_CR7","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1182\/blood.V98.7.2002","volume":"98","author":"KW Peng","year":"2001","unstructured":"Peng KW, Ahmann GJ, Pham L, Greipp PR, Cattaneo R, Russell SJ (2001) Systemic therapy of myeloma xenografts by an attenuated measles virus. Blood 98(7):2002\u20132007","journal-title":"Blood"},{"issue":"5","key":"602_CR8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nm0502-527","volume":"8","author":"KW Peng","year":"2002","unstructured":"Peng KW, Facteau S, Wegman T, O\u2019Kane D, Russell SJ (2002) Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides. Nat Med 8(5):527\u2013531","journal-title":"Nat Med"},{"issue":"10","key":"602_CR9","first-page":"2462","volume":"63","author":"LK Phuong","year":"2003","unstructured":"Phuong LK, Allen C, Peng KW et al (2003) Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme. Cancer Res 63(10):2462\u20132469","journal-title":"Cancer Res"},{"issue":"8","key":"602_CR10","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/mt.2009.92","volume":"17","author":"ID Iankov","year":"2009","unstructured":"Iankov ID, Hillestad ML, Dietz AB, Russell SJ, Galanis E (2009) Converting tumor-specific markers into reporters of oncolytic virus infection. Mol Ther 17(8):1395\u20131403","journal-title":"Mol Ther"},{"issue":"1","key":"602_CR11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/pros.20857","volume":"69","author":"P Msaouel","year":"2009","unstructured":"Msaouel P, Iankov ID, Allen C et al (2009) Engineered measles virus as a novel oncolytic therapy against prostate cancer. Prostate 69(1):82\u201391","journal-title":"Prostate"},{"key":"602_CR12","doi-asserted-by":"crossref","unstructured":"Yanagi Y, Takeda M, Ohno S (2006) Measles virus: cellular receptors, tropism and pathogenesis. J Gen Virol 87:2767\u20132779","DOI":"10.1099\/vir.0.82221-0"},{"issue":"2","key":"602_CR13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10549-006-9200-5","volume":"99","author":"CJ McDonald","year":"2006","unstructured":"McDonald CJ, Erlichman C, Ingle JN, Rosales GA, Allen C, Greiner SM, Harvey ME, Zollman PJ, Russell SJ, Galanis E (2006) A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer. Breast Cancer Res Treat 99(2):177\u2013184","journal-title":"Breast Cancer Res Treat"},{"issue":"14","key":"602_CR14","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1158\/0008-5472.CAN-04-0884","volume":"64","author":"BD Anderson","year":"2004","unstructured":"Anderson BD, Nakamura T, Russell SJ, Peng KW (2004) High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus. Cancer Res 64(14):4919\u20134926","journal-title":"Cancer Res"},{"issue":"7","key":"602_CR15","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1182\/blood-2004-11-4558","volume":"106","author":"L Heinzerling","year":"2005","unstructured":"Heinzerling L, Kunzi V, Oberholzer PA, Kundig T, Naim H, Dummer R (2005) Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells. Blood 106(7):2287\u20132294","journal-title":"Blood"},{"issue":"1","key":"602_CR16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/sj.mt.6300020","volume":"15","author":"ID Iankov","year":"2007","unstructured":"Iankov ID, Blechacz B, Liu C et al (2007) Infected cell carriers: a new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy. Mol Ther 15(1):114\u2013122","journal-title":"Mol Ther"},{"issue":"7","key":"602_CR17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1089\/10430340252898984","volume":"13","author":"C Demaison","year":"2002","unstructured":"Demaison C, Parsley K, Brouns G et al (2002) High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of immunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther 13(7):803\u2013813","journal-title":"Hum Gene Ther"},{"issue":"15","key":"602_CR18","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1128\/JVI.02427-05","volume":"80","author":"JA Noser","year":"2006","unstructured":"Noser JA, Towers GJ, Sakuma R et al (2006) Cyclosporine increases human immunodeficiency virus type 1 vector transduction of primary mouse cells. J Virol 80(15):7769\u20137774","journal-title":"J Virol"},{"issue":"11","key":"602_CR19","doi-asserted-by":"crossref","first-page":"9568","DOI":"10.1128\/JVI.73.11.9568-9575.1999","volume":"73","author":"WP Duprex","year":"1999","unstructured":"Duprex WP, McQuaid S, Hangartner L, Billeter MA, Rima BK (1999) Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus. J Virol 73(11):9568\u20139575","journal-title":"J Virol"},{"issue":"17","key":"602_CR20","doi-asserted-by":"crossref","first-page":"7972","DOI":"10.1128\/JVI.74.17.7972-7979.2000","volume":"74","author":"WP Duprex","year":"2000","unstructured":"Duprex WP, McQuaid S, Roscic-Mrkic B, Cattaneo R, McCallister C, Rima BK (2000) In vitro and in vivo infection of neural cells by a recombinant measles virus expressing enhanced green fluorescent protein. J Virol 74(17):7972\u20137979","journal-title":"J Virol"},{"issue":"12","key":"602_CR21","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/j.1537-2995.2006.01033.x","volume":"46","author":"AB Dietz","year":"2006","unstructured":"Dietz AB, Bulur PA, Emery RL et al (2006) A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers. Transfusion 46(12):2083\u20132089","journal-title":"Transfusion"},{"issue":"3","key":"602_CR22","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1006\/bbrc.2000.3372","volume":"275","author":"AB Dietz","year":"2000","unstructured":"Dietz AB, Bulur PA, Knutson GJ, Matasic R, Vuk-Pavlovic S (2000) Maturation of human monocyte-derived dendritic cells studied by microarray hybridization. Biochem Biophys Res Commun 275(3):731\u2013738","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"602_CR23","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1128\/CVI.00008-08","volume":"15","author":"IH Haralambieva","year":"2008","unstructured":"Haralambieva IH, Ovsyannikova IG, Vierkant RA, Poland GA (2008) Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity. Clin Vaccine Immunol 15(7):1054\u20131059","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"602_CR24","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/infdis\/162.5.1036","volume":"162","author":"RT Chen","year":"1990","unstructured":"Chen RT, Markowitz LE, Albrecht P et al (1990) Measles antibody: reevaluation of protective titers. J Infect Dis 162(5):1036\u20131042","journal-title":"J Infect Dis"},{"issue":"3","key":"602_CR25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0732-8893(98)00069-8","volume":"33","author":"BJ Ward","year":"1999","unstructured":"Ward BJ, Aouchiche S, Martel N et al (1999) Measurement of measles virus-specific neutralizing antibodies: evaluation of the syncytium inhibition assay in comparison with the plaque reduction neutralization test. Diagn Microbiol Infect Dis 33(3):147\u2013152","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"602_CR26","first-page":"91","volume":"30","author":"SA Eltarhouny","year":"2008","unstructured":"Eltarhouny SA, Elsawy WH, Radpour R, Hahn S, Holzgreve W, Zhong XY (2008) Genes controlling spread of breast cancer to lung \u201cgang of 4\u201d. Exp Oncol 30(2):91\u201395","journal-title":"Exp Oncol"},{"key":"602_CR27","first-page":"213","volume":"330","author":"SJ Russell","year":"2009","unstructured":"Russell SJ, Peng KW (2009) Measles virus for cancer therapy. Curr Top Microbiol Immunol 330:213\u2013241","journal-title":"Curr Top Microbiol Immunol"},{"issue":"5","key":"602_CR28","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1378\/chest.126.5.1529","volume":"126","author":"S Ren","year":"2004","unstructured":"Ren S, Terman DS, Bohach G et al (2004) Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer. Chest 126(5):1529\u20131539","journal-title":"Chest"},{"issue":"8","key":"602_CR29","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/thx.54.8.707","volume":"54","author":"DR Thickett","year":"1999","unstructured":"Thickett DR, Armstrong L, Millar AB (1999) Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusions. Thorax 54(8):707\u2013710","journal-title":"Thorax"},{"issue":"5","key":"602_CR30","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejim.2007.09.014","volume":"19","author":"S Bielsa","year":"2008","unstructured":"Bielsa S, Salud A, Martinez M et al (2008) Prognostic significance of pleural fluid data in patients with malignant effusion. Eur J Intern Med 19(5):334\u2013339","journal-title":"Eur J Intern Med"},{"issue":"2","key":"602_CR31","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ejcts.2004.03.010","volume":"26","author":"A Crnjac","year":"2004","unstructured":"Crnjac A, Sok M, Kamenik M (2004) Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma. Eur J Cardiothorac Surg 26(2):432\u2013436","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"602_CR32","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1183\/09031936.06.00097505","volume":"27","author":"K Psathakis","year":"2006","unstructured":"Psathakis K, Calderon-Osuna E, Romero-Romero B et al (2006) The neutrophilic and fibrinolytic response to talc can predict the outcome of pleurodesis. Eur Respir J 27(4):817\u2013821","journal-title":"Eur Respir J"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0602-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-009-0602-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0602-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T12:14:47Z","timestamp":1590236087000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-009-0602-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,6]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["602"],"URL":"https:\/\/doi.org\/10.1007\/s10549-009-0602-z","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,6]]}}}